Pricing Log in Create free account

Nautilus Biotechnology, Inc. (NAUT) vs Vogenx Inc (VOGX)

Nautilus Biotechnology, Inc. and Vogenx Inc are both Biotechnology companies. Nautilus Biotechnology, Inc. and Vogenx Inc are of similar size ($273.9M and $270.8M). Across the 3 metrics below, Vogenx Inc leads on 2 and Nautilus Biotechnology, Inc. on 1.

Valuation

Metric NAUT VOGX Biotechnology median
P/E n/m — 10.60
P/S n/m n/m 9.40
P/B 2.43 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (20.76%) — (32.88%)
Free cash flow yield (19.43%) 0.00% (23.13%)

Profitability

Metric NAUT VOGX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (41.01%) — (51.96%)
Return on assets (33.49%) — (46.06%)
Return on invested capital (133.48%) 0.00% 0.00%

Growth

Metric NAUT VOGX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 16.07% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NAUT VOGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.25 0.44 4.97
Net debt to EBITDA 1.67 — 1.01

Dividend

Metric NAUT VOGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NAUT VOGX Biotechnology median
Market cap 273.85m 270.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack